Towards selective antagonists of T-type calcium channels : Design, characterization and potential applications of NNC 55-0396MING LI; BONDO HANSEN, J; LUPING HUANG et al.Cardiovascular drug reviews (Print). 2005, Vol 23, Num 2, pp 173-196, issn 0897-5957, 24 p.Article

Mechanism-Based Inactivation of Cytochrome P450 3A4 by Mibefradil through Heme DestructionFOTI, Robert S; ROCK, Dan A; PEARSON, Josh T et al.Drug metabolism and disposition. 2011, Vol 39, Num 7, pp 1188-1195, issn 0090-9556, 8 p.Article

Pharmacologic and pharmacokinetic profile of mibefradil, a T- and L-type calcium channel antagonistABERNETHY, D. R.The American journal of cardiology. 1997, Vol 80, Num 4B, pp 4C-11C, issn 0002-9149Article

Safety of mibefradil, a new once-a-day, selective T-type calcium channel antagonistKOBRIN, I; CHARLON, V; LINDBERG, E et al.The American journal of cardiology. 1997, Vol 80, Num 4B, pp 40C-46C, issn 0002-9149Article

The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenonBELTRAME, John F; TURNER, Stuart P; LESLIE, Sue L et al.Journal of the American College of Cardiology. 2004, Vol 44, Num 1, pp 57-62, issn 0735-1097, 6 p.Article

Pharmacologic and therapeutic differences among calcium channel antagonists : Profile of mibefradil, a new calcium antagonistTRIGGLE, D. J.The American journal of cardiology. 1996, Vol 78, Num 9A, pp 7-12, issn 0002-9149Conference Paper

ROLE FOR VOLTAGE GATED CALCIUM CHANNELS IN CALCITONIN GENE-RELATED PEPTIDE RELEASE IN THE RAT TRIGEMINOVASCULAR SYSTEMAMRUTKAR, D. V; PLOUG, K. B; OLESEN, J et al.Neuroscience. 2011, Vol 172, Num 1, pp 510-517, issn 0306-4522, 8 p.Article

T-type calcium channels in the regulation of afferent and efferent arterioles in ratsFENG, Ming-Guo; MING LI; NAVAR, L. Gabriel et al.American journal of physiology. Renal physiology. 2004, Vol 55, Num 2, pp F331-F337, issn 1931-857XArticle

Comparison of the efficacy and safety of losartan (50-100 mg) with the T-type calcium channel blocker mibefradil (50-100 mg) in mild to moderate hypertensionCHUNG, O; HINDER, M; SHARMA, A. M et al.Fundamental & clinical pharmacology. 2000, Vol 14, Num 1, pp 31-41, issn 0767-3981Conference Paper

Utilisation des inhibiteurs calciques dans le traitement de l'insuffisance cardiaque : Réévaluation des stratégies thérapeutiques = Calcium antagonist use in heart failure : A re-evaluation of treatment optionsGATTIS, Wendy; O'CONNOR, Christopher M.Drugs (Basel). 2000, Vol 59, pp 17-24, issn 0012-6667, NS2Article

Mycophenolate mofetil decreases endothelial prostaglandin E₂ in response to allogeneic T cells or cytokinesBLAHETA, R. A; NELSON, K; OPPERMANN, E et al.Transplantation. 2000, Vol 69, Num 9, pp 1977-1981, issn 0041-1337Article

Drug-drug interactions of new active substances : mibefradil exampleKRAYENBÜHL, J. C; VOZEH, S; KONDO-OESTREICHER, M et al.European journal of clinical pharmacology. 1999, Vol 55, Num 8, pp 559-565, issn 0031-6970Conference Paper

The efficacy and safety of mibefradil in subgroups of patients with chronic stable angina pectorisCHARLON, V; KOBRIN, I.International journal of clinical practice (Esher). 1998, Vol 52, Num 4, pp 257-264, issn 1368-5031Article

T-channel blockade: a new advance in the treatment of cardiovascular diseasesWAEBER, Bernard; PRATT, Craig.Cardiology. 1998, Vol 89, issn 0008-6312, 48 p., SUP1Conference Proceedings

Metabolism of the calcium antagonist, mibefradil (POSICOR, Ro 40-5967). Part II. Metabolism in hepatic microsomes from rat, marmoset, cynomolgus monkey, rabbit and manWILTSHIRE, H. R; SUTTON, B. M; HEEPS, G et al.Xenobiotica (London. Print). 1997, Vol 27, Num 6, pp 539-556, issn 0049-8254Article

Voltage-gated divalent currents in descending vasa recta pericytesZHONG ZHANG; HAI LIN; CHUNHUA CAO et al.American journal of physiology. Renal physiology. 2010, Vol 68, Num 4, issn 1931-857X, F862-F871Article

T-type Ca²⁺ channels mediate propagation of odor-induced Ca²⁺ transients in rat olfactory receptor neuronsGAUTAM, S. H; OTSUGURO, K.-I; ITO, S et al.Neuroscience. 2007, Vol 144, Num 2, pp 702-713, issn 0306-4522, 12 p.Article

A role of functional T-type Ca²⁺ channel in hepatocellular carcinoma cell proliferationYAJUAN LL; SHUANG LIU; FENGMIN LU et al.Oncology reports. 2009, Vol 22, Num 5, pp 1229-1235, issn 1021-335X, 7 p.Article

Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Ca_v1.2MOOSMANG, Sven; HAIDER, Nicole; BRÜDERL, Birgit et al.Circulation research. 2006, Vol 98, Num 1, pp 105-110, issn 0009-7330, 6 p.Article

MECHANISMS OF POTASSIUM-AND CAPSAICIN-INDUCED AXONAL CALCITONIN GENE-RELATED PEPTIDE RELEASE : INVOLVEMENT OF L-AND T-TYPE CALCIUM CHANNELS AND TRPV1 BUT NOT SODIUM CHANNELSSPITZER, M. J. S; REEH, P. W; SAUER, S. K et al.Neuroscience. 2008, Vol 151, Num 3, pp 836-842, issn 0306-4522, 7 p.Article

Rhabdomyolysis induced by mibefradil in a patient treated with cyclosporine and simvastatinWOMBOLT, D. G; JACKSON, A; PUNN, R et al.Journal of clinical pharmacology. 1999, Vol 39, Num 3, pp 310-312, issn 0091-2700Conference Paper

Pharmacokinetic interaction between oral cyclosporin and mibefradil in stabilized post-renal-transplant patientsSPOENDLIN, M; PETERS, J; WELKER, H et al.Nephrology, dialysis, transplantation (Print). 1998, Vol 13, Num 7, pp 1787-1791, issn 0931-0509Article

Dose-response characteristics of mibefradil, a novel calcium antagonist, in the treatment of essential hypertensionOPARIL, S; KOBRIN, I; ABERNETHY, D. R et al.American journal of hypertension. 1997, Vol 10, Num 7, pp 735-742, issn 0895-7061, 1Article

Mibefradil, a T-type Ca²⁺ channel blocker, protects against mesenteric ischemia-reperfusion-induced oxidative injury and histologic alterations in intestinal mucosa in ratsOZTURK, Hayrettin; OZTURK, Hulya; DURAN, Hatun et al.Digestive diseases and sciences. 2006, Vol 51, Num 8, pp 1454-1460, issn 0163-2116, 7 p.Article

T-type calcium channels : An emerging therapeutic target for the treatment of painSNUTCH, Terrance P; DAVID, Laurence S.Drug development research. 2006, Vol 67, Num 4, pp 404-415, issn 0272-4391, 12 p.Article